ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

UPR Uniphar Plc

223.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Uniphar Plc LSE:UPR London Ordinary Share IE00BJ5FQX74 ORD EUR0.08 (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 223.00 220.00 226.00 223.00 223.00 223.00 27,825 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 2.55B 44.82M 0.1641 13.59 608.82M
Uniphar Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker UPR. The last closing price for Uniphar was 223p. Over the last year, Uniphar shares have traded in a share price range of 180.00p to 300.00p.

Uniphar currently has 273,015,254 shares in issue. The market capitalisation of Uniphar is £608.82 million. Uniphar has a price to earnings ratio (PE ratio) of 13.59.

Uniphar Share Discussion Threads

Chat Pages: 1
DateSubjectAuthorDiscuss
03/2/2023
08:32
Uniphar Holding(s) in Company
johnwise
03/3/2022
10:46
03/03/2022 7:31am

RNS Number : 5134D

Acquisition of Ordinary Shares

Uniphar PLC Director/PDMR Shareholding

johnwise
01/3/2022
16:03
Uniphar plc is regarded as a diversified healthcare services in the UK and Republic of Ireland. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers, and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare products to pharmacies and hospitals. These highly innovative methodologies and cutting-edge initiatives will be effectively incorporated into the firm’s financial prospects, where net profit soared to £48,122m from £27,811m, thus trading ahead of expectations, thus resulting in a profit growth of 26.3%. Despite the favourable corporate news, the firm is undervalued since it is trading at a P/E ratio of 16.9, which is below the healthcare sector P/E ratio of 26.3. Consequently, it implies that Uniphar plc is expected to surge in value, as illustrated by the robust EPS growth of 16.2% and attractive P/B ratio of 4.08.



Keep up to date with WealthOracle AM

km18
01/3/2022
07:59
01/03/2022 7:00am

RNS Number : 1188D

Uniphar PLC 2021 Preliminary Results

johnwise
01/2/2021
17:47
Great company, looking to expand into NA and Europe soon.
kevraff
01/2/2021
15:25
Dublin, London | 20 January 2021: Uniphar plc ("Uniphar" or the "Company") today announces it has applied to the London Stock Exchange to change the currency in which the Company's ordinary shares are traded on the London Stock Exchange from Euro to Sterling. It is expected this change will become effective at 8.00 am on 1 February 2021.
arcadian
01/2/2021
14:26
Whats the story here?
netcurtains
01/2/2021
09:02
is that a very fat finger?
bg23
02/9/2020
07:43
!FOLLOWFEED
molatovkid
Chat Pages: 1

Your Recent History

Delayed Upgrade Clock